Evolet

What Evolet does

Evolet is an India-headquartered pharmaceutical manufacturer and exporter operating two WHO GMP-compliant production units in Roorkee, Uttarakhand, with a corporate office and R&D Centre in Gurugram, Haryana. The company manufactures and distributes a portfolio of 1,200+ generic pharmaceutical products across tablets, capsules, ointments, and liquids, spanning more than 15 therapeutic segments including antibiotics, antifungals, antimalarials, CNS drugs, antidiabetics, NSAIDs, gastrointestinal, respiratory, and dermatological treatments. Its business model is built on proprietary licensed products developed in-house and at partner facilities, with full-service regulatory support covering registration, certification, and pharmacovigilance.

The company monetizes through B2B export of pharmaceutical formulations to a distributor and healthcare-provider network spanning 30 countries across Central Asia, South/Southeast Asia, the Caucasus, Eastern Europe, the Caribbean, the Middle East, and Africa. Distribution is executed via a developed representative network with regional offices in Tajikistan, Uzbekistan, Afghanistan, Russia, Kazakhstan, and Georgia, supported by well-established sales channels for timely delivery. The company has accumulated 1,712 regulatory registration authorizations across its operating geographies, which constitutes the core regulatory barrier protecting its export footprint.

Additional capabilities include market research and demand analysis for partner companies' portfolio construction, pharmacovigilance under international standards, and R&D for pharmaceutical development. Leadership disclosure is limited to two named directors (Sadullo Abdulloev and Zafarkhon Mirzoev); no broader management team, funding history, or revenue figures are publicly disclosed.

Name

Evolet

Legal name

Evolet

Website

https://evolet.in

Company type

Private

Founded year

2011

Operating status

Operating

Headcount range

11–50 employees

Short description

Evolet is an India-based pharmaceutical manufacturer that produces and exports 1,200+ generic formulations (tablets, capsules, ointments, liquids) through a distribution network spanning 30 countries, primarily in Central Asia, the CIS, and emerging markets.

Ownership category

akta.pro rank

Product category

Generic Pharmaceutical Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (3254), Drugs and Druggists' Sundries Merchant Wholesalers (424210)

SIC

Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Generic Hospital & Institutional Products (HLAIABAL)

akta.pro secondary industries

Full-Line Pharmaceutical Wholesalers (HLAIAJAA), Cardiometabolic Pharmaceuticals (Cardiovascular/Diabetes/Obesity) (HLAIAAAE)

Keywords

• Generic pharmaceuticals
• Pharmaceutical manufacturing
• Drug formulations
• WHO GMP manufacturing
• Pharmaceutical distribution

Headquarters

HQ city

New Delhi

HQ country

India

HQ region

Asia

Offices11 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D

Revenue model

1. Pharmaceutical Products Manufacturing and Distribution: Evolet manufactures and distributes pharmaceutical formulations including tablets, capsules, ointments, and liquids across domestic (India) and export markets. The company develops and creates own licensed products at production facilities and provides full-service support including regulatory registration, marketing, pharmacovigilance, and distribution management.

Go-to-market motion1 record

Distribution channels1 record

Core offering

Evolet manufactures and distributes generic pharmaceutical formulations including tablets, capsules, ointments, and liquids at WHO GMP compliant facilities in Roorkee, India. The company offers over 1,200 products across multiple therapeutic segments (antibiotics, antifungals, antihistamines, CNS, diabetic, NSAIDs, gastrointestinal, hematinics, antimalarials, anthelmintics, dermals, anticoughs and antiemetics) and exports to 30 countries, providing full-service support including regulatory registration, marketing, pharmacovigilance, and distribution management.

Product overview

Evolet is a pharmaceutical company offering a broad portfolio of over 1200 generic pharmaceutical products across multiple dosage forms. The product portfolio is organized around core formulation types: Tablets (506 products including uncoated, film-coated, enteric-coated, dispersible, and sustained/controlled release variants), Capsules (59 products), External Preparations (137 products including ointments, creams, gels, lotions, shampoos), and Internal Preparations (119 products including syrups, suspensions, and solutions). Products span therapeutic segments including Gastrointestinal, Antibiotics & Antibacterials, Antifungals, Antihistamines, CNS/Psychiatric, Respiratory/Cough, Diabetic, NSAIDs, Hematinics, Antimalarials, Anthelmintics, and Dermatological treatments. Manufacturing is WHO GMP compliant with facilities in Roorkee, Uttarakhand, India.

Differentiator

Problem solved

Functional benefit

Products and services

• Tablets (Pharmaceutical)
• Capsules (Pharmaceutical)
• External Preparations (Ointments, Creams, Gels, Lotions)
• Internal Preparations (Syrups, Suspensions, Solutions, Drops)
• Antibiotics & Antibacterials
• Antifungals
• CNS (Central Nervous System) Products
• Diabetic Products
• Antimalarials
• GIT (Gastrointestinal) Products

Quantifiable outcome

• Presence in 30 countries with 2000+ employees
• +2 more outcomes

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Three partnerships are on record, tiered minor.

• LucidminorChannel Partner/ Reseller/ DistributorPharmaceutical distribution partner visible in Evolet's partner logos section
• Healing PharmaminorChannel Partner/ Reseller/ DistributorPharmaceutical distribution partner visible in Evolet's partner logos section
• Tablet IndiaminorChannel Partner/ Reseller/ DistributorPharmaceutical distribution partner visible in Evolet's partner logos section

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Glenmark Pharmaceuticals: India-based generic and specialty pharma company with manufacturing in India and emerging-markets commercial presence across CIS, Africa and Asia; overlaps with Evolet in dermatology, anti-infectives and oral solids.
• Sun Pharmaceutical Industries: India's largest specialty and generic pharma manufacturer with global manufacturing and registration footprint; competes with Evolet in generics and represents the upper-bound peer on scale.
• Dr. Reddy's Laboratories: Major India-based generic and biosimilar manufacturer with global commercial footprint including CIS, Africa and emerging Asia; comparable in oral solids/liquids manufacturing and registration-driven market access strategy.
• Zydus Lifesciences (formerly Cadila Healthcare): Diversified Indian pharmaceutical manufacturer with strong generics, API and emerging-market export business; comparable manufacturing breadth and registration-driven market access approach.
• Lupin Limited: Indian generic pharma manufacturer with broad therapeutic coverage (anti-infectives, CNS, cardiovascular) and export presence across emerging markets; overlapping product mix and similar GMP-based export model.
• Aurobindo Pharma: Large Indian generic pharma manufacturer with significant WHO GMP capacity and deep emerging-market distribution; competing portfolio of antibiotics, antiretrovirals, antimalarials and CNS products across the same geographies Evolet serves.

Direct peers

• Emcure Pharmaceuticals: Indian generic manufacturer with significant emerging-market presence including CIS, Africa and Southeast Asia; broad dosage-form portfolio and WHO GMP facilities make it one of the closest scale-and-mix comparables to Evolet.
• Hetero Labs: India-headquartered generics and ARV manufacturer with strong WHO Prequalification track record and deep emerging-market distribution; similar export-driven, registration-heavy business model.
• Cipla: India-headquartered global generic pharmaceuticals manufacturer with broad therapeutic coverage, WHO GMP manufacturing, and strong presence across emerging markets including Africa, South Asia and CIS — directly comparable to Evolet in product categories, regulatory model, and export-led GTM.
• Macleods Pharmaceuticals: Indian generic manufacturer specializing in anti-infectives, anti-malarials, and a broad emerging-market export portfolio; closest peer to Evolet in scale, therapeutic mix, and focus on WHO Prequalification markets.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights5 records

Customer concentration

• Facebookfacebook.com/evolet-healthcare-1522818857950805
• LinkedInlinkedin.com/company/evolet-healthcare

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Evolet